BRG Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.…
Industry Peers
Specialty ChemicalsKey Statistics
About Borregaard (OSL: BRG)
›
Borregaard (OSL: BRG) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,193 employees.
The shares were at 152.00 NOK on 19 November 2026, down 17.8% over 52 weeks. Its 52-week range is 137.60 NOK to 200.50 NOK: the price is 24.2% below the high and 10.5% above the low.
At a market capitalisation of 15.15B NOK, it trades at 56.5 times trailing earnings and 15.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a premium of 66% for BRG. It pays a dividend yielding 3.08% (it pays out 176% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Borregaard reports return on equity of 10.6%, an operating margin of 16.2% and revenue up 5.3% year over year.
Its debt exceeds its cash by 1.86B NOK, a debt-to-equity ratio of 0.37. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 5 analysts cover the stock; their mean price target of 175.60 NOK is 15.5% above the current price. The next earnings report is expected on 3 February 2027.